Extended Duration Vascular Endothelial Growth Factor Inhibition in the Eye: Failures, Successes, and Future Possibilities
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Extended Duration Vascular Endothelial Growth Factor Inhibition in the Eye: Failures, Successes, and Future Possibilities
Authors
Keywords
-
Journal
Pharmaceutics
Volume 10, Issue 1, Pages 21
Publisher
MDPI AG
Online
2018-01-29
DOI
10.3390/pharmaceutics10010021
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Brolucizumab Versus Aflibercept in Participants with Neovascular Age-Related Macular Degeneration: A Randomized Trial
- (2017) Pravin U. Dugel et al. OPHTHALMOLOGY
- Characterization of liposomal carriers for the trans-scleral transport of Ranibizumab
- (2017) Rini Rachel Joseph et al. Scientific Reports
- Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema
- (2016) John A. Wells et al. OPHTHALMOLOGY
- Implantable MicroPump for Drug Delivery in Patients with Diabetic Macular Edema
- (2014) Mark Humayun et al. Translational Vision Science & Technology
- One-Year Feasibility Study of Replenish MicroPump for Intravitreal Drug Delivery: A Pilot Study
- (2014) Juan-Carlos Gutiérrez-Hernández et al. Translational Vision Science & Technology
- Intravitreal Aflibercept Injection for Neovascular Age-related Macular Degeneration
- (2013) Ursula Schmidt-Erfurth et al. OPHTHALMOLOGY
- Treatment of Diabetic Macular Edema With a Designed Ankyrin Repeat Protein That Binds Vascular Endothelial Growth Factor: A Phase I/II Study
- (2012) Peter A. Campochiaro et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Binding and neutralization of vascular endothelial growth factor (VEGF) and related ligands by VEGF Trap, ranibizumab and bevacizumab
- (2012) Nicholas Papadopoulos et al. ANGIOGENESIS
- KH902 suppresses high glucose-induced migration and sprouting of human retinal endothelial cells by blocking VEGF and PIGF
- (2012) X. Chen et al. DIABETES OBESITY & METABOLISM
- Effects of intravitreal injection of KH902, a vascular endothelial growth factor receptor decoy, on the retinas of streptozotocin-induced diabetic rats
- (2012) J. Huang et al. DIABETES OBESITY & METABOLISM
- Ranibizumab and Bevacizumab for Treatment of Neovascular Age-related Macular Degeneration
- (2012) Daniel F. Martin et al. OPHTHALMOLOGY
- Intravitreal Aflibercept (VEGF Trap-Eye) in Wet Age-related Macular Degeneration
- (2012) Jeffrey S. Heier et al. OPHTHALMOLOGY
- Intravitreal Ranibizumab for Diabetic Macular Edema with Prompt versus Deferred Laser Treatment
- (2012) Michael J. Elman et al. OPHTHALMOLOGY
- Ranibizumab versus Bevacizumab to Treat Neovascular Age-related Macular Degeneration
- (2012) Usha Chakravarthy et al. OPHTHALMOLOGY
- Prevention of Experimental Choroidal Neovascularization and Resolution of Active Lesions by VEGF Trap in Nonhuman Primates
- (2011) T. Michael Nork ARCHIVES OF OPHTHALMOLOGY
- Mini Drug Pump for Ophthalmic Use
- (2010) Saloomeh Saati et al. CURRENT EYE RESEARCH
- A Phase 1 Study of KH902, a Vascular Endothelial Growth Factor Receptor Decoy, for Exudative Age-Related Macular Degeneration
- (2010) Ming Zhang et al. OPHTHALMOLOGY
- Chaperone-Assisted Crystallography with DARPins
- (2008) Gaby Sennhauser et al. STRUCTURE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started